This is a preview of subscription content, log in via an institution to check access.
Notes
total expected costs were estimated using direct medical costs in patients with SCAR treated at two hospitals; calculated in US dollars using an exchange rate of 1 USD per 1116.6 Korean won
Reference
Park DJ, et al. Cost-effectiveness analysis of HLA-B5801 genotyping in the treatment of gout patients with chronic renal insufficiency in Korea. Arthritis care and research : 12 Jul 2014. Available from: URL: http://doi.org/10.1002/acr.22409
Rights and permissions
About this article
Cite this article
HLA-B5801 genotyping of gout reduces costs. PharmacoEcon Outcomes News 708, 6 (2014). https://doi.org/10.1007/s40274-014-1424-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1424-8